Fig. 7From: Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trialsSubgroup analysis of denosumab versus ZA in solid tumors. Forest plots of incidence of AE (A), serious AEs (B), and renal toxicity (C)Back to article page